Yesterday | CiteULike
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients.
Cochrane database of systematic reviews , No. 4. Abstract BACKGROUND: Calcimimetic agents have recently been evaluated in the treatment of secondary hyperparathyroidism as add-on therapy to calcitriol and vitamin D analogues and dietary phosphate binders.
DIET IS KEY Carrots are a source of calcium Kidney is a vital organ of the body with multiple roles.
Protective Role of Vitamin D on the Cardiovascular System
Heart disease is a broad term that describes a range of diseases that affect the cardiovascular system and result in approximately 630,000 deaths annually in the United States.1 Cardiovascular disease is the leading cause of death of both men and women above the age of 35 among all racial and ethnic groups.2 While risk factors such as increased ...
Ranbaxy Labs subsidiary to launch hyperparathyroidism generic
PRINCETON,A N.J. The U.S. subsidiary of an Indian generic drug maker will launch an authorized generic version of a hyperparathyroidism drug.
Also on Topix